Document Detail


Intermediate-term outcome of variable dose mitomycin C filtering surgery.
MedLine Citation:
PMID:  9022119     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: Trabeculectomy with adjunctive mitomycin C is associated with high success rates in studies with follow-up of less than 1 year. This report evaluates the visual and intraocular pressure (IOP) outcome in eyes after trabeculectomy with adjunctive mitomycin C 1 to 3 years after surgery in a predominantly white group (98.1%). METHODS: The records of 157 eyes of 157 consecutive patients, aged 18 or older, who underwent mitomycin C trabeculectomies for uncontrolled glaucoma of various causes were reviewed. All surgeries were performed between April 1991 and June 1993. The concentration of mitomycin C varied from 0.2 to 0.5 mg/ml and was applied for 30 seconds to 5 minutes (only one patient received 0.2 mg/ml). Of the 157 eyes, 110 eyes were at high risk for failure (previous surgeries or inflammatory glaucoma). Thirty-nine eyes had preoperative IOP < or = 21 mmHg. RESULTS: The mean preoperative IOP was 29.4 +/- 10.3 mmHg. This was reduced to 13.0 +/- 7.6 mmHg at 1 year, 11.5 +/- 6.4 mmHg at 2 years, and 13.4 +/- 7.3 mmHg at 3 years. Cumulative survival rate by life-table analysis was 94.2% +/- 1.9% at 1 year, 92.1% +/- 2.4% at 2 years, and 88.7% +/- 4.0% at 3 years, where failure was defined as reoperation for control of IOP. Complications included cataract formation-progression (n = 31), hyphema (n = 26), choroidal detachment (n = 21), hypotony maculopathy (n = 5), and endophthalmitis (n = 2). Vision deteriorated in 29 eyes and improved by 2 or more Snellen visual acuity lines in 29 eyes. CONCLUSION: The IOP reduction after mitomycin C filtering surgery is sustained in the intermediate-term, 1 to 3 years, follow-up period.
Authors:
J C Cheung; M M Wright; S Murali; J E Pederson
Related Documents :
23920019 - Population-based study of disability and institutionalization after transient ischemic ...
7902819 - The importance of cellular changes in the conjunctiva of patients with uveitic glaucoma...
23818179 - Propionic acidemia and optic neuropathy: a report of two cases.
3587859 - Filtration surgery in black patients: early results in a west indian population.
11450719 - Trabulectomy outcomes in advanced glaucoma in nigeria.
2669939 - Prevention of the immediate intraocular pressure rise following argon laser trabeculopl...
23920019 - Population-based study of disability and institutionalization after transient ischemic ...
20708509 - Impact of therapeutic interventions on survival of patients with hepatic hydrothorax.
16455539 - Non-surgical primary treatment of chronic subdural haematoma: preliminary results of us...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Ophthalmology     Volume:  104     ISSN:  0161-6420     ISO Abbreviation:  Ophthalmology     Publication Date:  1997 Jan 
Date Detail:
Created Date:  1997-02-25     Completed Date:  1997-02-25     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7802443     Medline TA:  Ophthalmology     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  143-9     Citation Subset:  IM    
Affiliation:
Department of Ophthalmology, University of Minnesota, Minneapolis 55455, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Chemotherapy, Adjuvant
Female
Glaucoma / physiopathology,  therapy*
Humans
Intraocular Pressure / physiology*
Life Tables
Male
Middle Aged
Mitomycin / administration & dosage*
Nucleic Acid Synthesis Inhibitors / administration & dosage*
Ophthalmic Solutions
Postoperative Complications
Trabeculectomy*
Treatment Outcome
Visual Acuity / physiology*
Chemical
Reg. No./Substance:
0/Nucleic Acid Synthesis Inhibitors; 0/Ophthalmic Solutions; 50-07-7/Mitomycin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A comparison of dorzolamide and timolol in patients with pseudoexfoliation and glaucoma or ocular hy...
Next Document:  Glaucoma in phakomatosis pigmentovascularis.